1. Home
  2. LTRN vs UBX Comparison

LTRN vs UBX Comparison

Compare LTRN & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • UBX
  • Stock Information
  • Founded
  • LTRN 2013
  • UBX 2009
  • Country
  • LTRN United States
  • UBX United States
  • Employees
  • LTRN N/A
  • UBX N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LTRN Health Care
  • UBX Health Care
  • Exchange
  • LTRN Nasdaq
  • UBX Nasdaq
  • Market Cap
  • LTRN 33.7M
  • UBX 38.6M
  • IPO Year
  • LTRN 2020
  • UBX 2018
  • Fundamental
  • Price
  • LTRN $5.08
  • UBX $2.10
  • Analyst Decision
  • LTRN Hold
  • UBX Strong Buy
  • Analyst Count
  • LTRN 1
  • UBX 2
  • Target Price
  • LTRN N/A
  • UBX $7.00
  • AVG Volume (30 Days)
  • LTRN 155.4K
  • UBX 364.5K
  • Earning Date
  • LTRN 03-17-2025
  • UBX 11-04-2024
  • Dividend Yield
  • LTRN N/A
  • UBX N/A
  • EPS Growth
  • LTRN N/A
  • UBX N/A
  • EPS
  • LTRN N/A
  • UBX N/A
  • Revenue
  • LTRN N/A
  • UBX N/A
  • Revenue This Year
  • LTRN N/A
  • UBX N/A
  • Revenue Next Year
  • LTRN N/A
  • UBX $33.62
  • P/E Ratio
  • LTRN N/A
  • UBX N/A
  • Revenue Growth
  • LTRN N/A
  • UBX N/A
  • 52 Week Low
  • LTRN $2.79
  • UBX $0.94
  • 52 Week High
  • LTRN $11.99
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 64.21
  • UBX 62.50
  • Support Level
  • LTRN $4.60
  • UBX $2.05
  • Resistance Level
  • LTRN $5.30
  • UBX $2.42
  • Average True Range (ATR)
  • LTRN 0.61
  • UBX 0.31
  • MACD
  • LTRN 0.06
  • UBX -0.01
  • Stochastic Oscillator
  • LTRN 68.99
  • UBX 41.67

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: